I
319.56
0.79 (0.25%)
| 前收盘价格 | 318.77 |
| 收盘价格 | 319.48 |
| 成交量 | 151,428 |
| 平均成交量 (3个月) | 612,242 |
| 市值 | 22,494,638,080 |
| 市盈率 (P/E TTM) | 97.43 |
| 预期市盈率 (P/E Forward) | 54.95 |
| 价格/销量 (P/S) | 8.78 |
| 股市价格/股市净资产 (P/B) | 15.47 |
| 52周波幅 | |
| 利润日期 | 6 Nov 2025 |
| 营业毛利率 | 18.29% |
| 营业利益率 (TTM) | 15.61% |
| 稀释每股收益 (EPS TTM) | 5.54 |
| 季度收入增长率 (YOY) | 28.80% |
| 季度盈利增长率 (YOY) | -31.30% |
| 总债务/股东权益 (D/E MRQ) | 131.40% |
| 流动比率 (MRQ) | 4.47 |
| 营业现金流 (OCF TTM) | 406.50 M |
| 杠杆自由现金流 (LFCF TTM) | 84.25 M |
| 资产报酬率 (ROA TTM) | 6.94% |
| 股东权益报酬率 (ROE TTM) | 37.92% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | Insulet Corporation | 看涨 | 看涨 |
AIStockmoo 评分
1.0
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.00 |
|
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Mid Growth |
| 内部持股比例 | 0.29% |
| 机构持股比例 | 102.56% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 432.00 (Canaccord Genuity, 35.19%) | 购买 |
| 中 | 380.00 (18.91%) | |
| 低 | 316.00 (Barclays, -1.11%) | 保留 |
| 平均值 | 381.50 (19.38%) | |
| 总计 | 9 购买, 1 保留 | |
| 平均价格@调整类型 | 331.90 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Canaccord Genuity | 24 Nov 2025 | 432.00 (35.19%) | 购买 | 337.53 |
| 07 Nov 2025 | 428.00 (33.93%) | 购买 | 319.82 | |
| BTIG | 21 Nov 2025 | 380.00 (18.91%) | 购买 | 331.17 |
| 13 Nov 2025 | 370.00 (15.78%) | 购买 | 332.67 | |
| RBC Capital | 21 Nov 2025 | 380.00 (18.91%) | 购买 | 331.17 |
| 07 Nov 2025 | 370.00 (15.78%) | 购买 | 319.82 | |
| Truist Securities | 21 Nov 2025 | 412.00 (28.93%) | 购买 | 331.17 |
| 07 Nov 2025 | 390.00 (22.04%) | 购买 | 319.82 | |
| UBS | 19 Nov 2025 | 400.00 (25.17%) | 购买 | 346.36 |
| 07 Nov 2025 | 355.00 (11.09%) | 保留 | 319.82 | |
| Barclays | 07 Nov 2025 | 316.00 (-1.11%) | 保留 | 319.82 |
| 05 Nov 2025 | 301.00 (-5.81%) | 保留 | 314.44 | |
| Wells Fargo | 07 Nov 2025 | 360.00 (12.65%) | 购买 | 319.82 |
| Jefferies | 06 Nov 2025 | 400.00 (25.17%) | 购买 | 323.40 |
| Stifel | 21 Oct 2025 | 370.00 (15.78%) | 购买 | 328.97 |
| Oppenheimer | 08 Sep 2025 | 365.00 (14.22%) | 购买 | 349.56 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合